Overinvested in NAB shares? Here are 2 alternative ASX 200 shares

There are some blue chips I'd rather buy than NAB.

| More on:
Couple looking at their phone surprised, symbolising a bargain buy.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

National Australia Bank Ltd (ASX: NAB) shares were a great investment in 2024, delivering a rise of more than 22%. However, with those gains, some shareholders may feel the portion of their portfolio invested in the ASX bank stock has grown too large and they'd prefer to allocate some of the gains elsewhere.

But what sorts of businesses would be good investments right now for NAB shareholders?

If I were looking to reallocate some of my gains from NAB shares, I would diversify away from the banking sector and instead put the investment money towards some different S&P/ASX 200 Index (ASX: XJO) sector opportunities.

So, let's take a look at two ASX shares outside the banking sector that could be attractive for potentially faster growth and less competition than NAB.

Sonic Healthcare Ltd (ASX: SHL)

NAB makes a large proportion of its earnings in Australia, so it could be useful to diversify by looking at a business with major earnings outside of Australia. There's also a risk to NAB earnings in the near term with the potential for rising mortgage arrears among its customers amid high interest rates and inflation. It may also be a good idea to consider a defensive ASX 200 stock to help counteract that threat.

Sonic Healthcare is a global pathology business. The ASX healthcare share has a presence in the United States, Australia, Germany, Switzerland, the United Kingdom, Belgium, and New Zealand.

The company plays an important part in the healthcare systems of the countries it operates in. Since we don't choose when we get sick, demand is fairly consistent throughout economic cycles.

This ASX 200 stock is seeing steady and long-term revenue growth from tailwinds in its operating countries, including ageing and growing populations. It wasn't surprising to me that Sonic's total revenue grew 10% in the first four months of FY25 – much stronger than what owners of NAB shares are seeing.

Sonic Healthcare is expecting operating profit (EBITDA) to grow by around 10% in FY25. Earnings growth looks positive in the coming years, with recent acquisitions, easing cost inflation and increasing usage of technology/artificial intelligence (AI) throughout the business to boost productivity.

The company has grown its dividend every year for the past decade and has a current dividend yield of around 3.8%.

REA Group Ltd (ASX: REA)

Owning NAB shares is a big bet on the Australian economy and largely the Australian property market. If investors want to profit from Australia's property market, another option outside of NAB would be to invest in the business that owns realestate.com.au.

REA Group's real estate portal receives an average of 132.4 million realestate.com.au monthly visits, four times more than its nearest competitor. That market strength allows the ASX 200 stock to increase listing prices regularly with little detriment.

The FY25 first quarter update highlighted the company's ability to grow revenue at a decent pace and for profit to rise even faster — quarterly revenue rose 21% to $413 million and operating profit (EBITDA) increased 23% to $236 million.

It also appears the company is experiencing similar success in India, which obviously has a much larger population than that of Australia and, therefore, greater potential. The FY25 first quarter saw revenue growth of 42% year over year in that market thanks to strong growth in adjacency services, as well as continued momentum on Housing.com.

Motley Fool contributor Tristan Harrison has positions in REA Group. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Sonic Healthcare. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

A smiling woman holds a Facebook like sign above her head.
Growth Shares

3 ASX growth shares I'd buy for the next 10 years

Let's see why these shares could be top picks for the long term.

Read more »

wheelchair user in an office talking on mobile phone
Growth Shares

Why I'd buy this ASX growth share instantly

I’m calling on this stock to deliver strong returns.

Read more »

A happy boy with his dad dabs like a hero while his father checks his phone.
Growth Shares

2 ASX growth shares to buy in June: experts

These businesses have strong growth potential.

Read more »

Rocket powering up and symbolising a rising share price.
Growth Shares

Buy these stellar ASX growth shares with $1,000

Analysts think these shares would be top buys right now.

Read more »

Overjoyed man celebrating success with yes gesture after getting some good news on mobile.
Growth Shares

These ASX growth shares could rise 18% to 30%

Let's see which shares are being tipped to rocket.

Read more »

Ecstatic woman looking at her phone outside with her fist pumped.
Growth Shares

Goldman Sachs tips this ASX 200 growth stock to rise 35%

Let's see what the broker is saying about this growing company.

Read more »

Two players on a field pump their fists in the air, indicating two of the best
Growth Shares

The ultimate ASX growth shares to buy with $5,000

Brokers are very bullish on these names. But why? Let's find out.

Read more »

Australian dollar notes in the pocket of a man's jeans, symbolising dividends.
Growth Shares

Where to invest $1,000 into ASX shares in June

These shares could be buys according to analysts.

Read more »